-
Mirabegron CAS 223673-61-8Mirabegron CAS 223673-61-8, is a beta-3 adrenergic receptor agonist used for treatment of overactive bladder.read more
Indications: overactive bladder, urinary frequency, urgency. -
Benserazide Hydrochloride CAS 14919-77-8Benserazide Hydrochloride CAS 14919-77-8, is a peripheral aromatic L-amino acid decarboxylase (AADC) inhibitor. It is not used as a standalone therapeutic agent but is almost exclusively combined...read more
-
Eltrombopag Olamine CAS 496775-62-3Eltrombopag Olamine CAS 496775-62-3, is a thrombopoietin receptor agonist (TPO-RA) that stimulates the production of platelets. It is a small-molecule, non-peptide agonist that mimics the action...read more
-
Upadacitinib CAS 1310726-60-3Upadacitinib CAS 1310726-60-3, is an oral Janus kinase (JAK) inhibitor that selectively inhibits the JAK1 subtype and exerts anti-inflammatory effects by modulating immune...read more
-
Mirdametinib CAS 391210-10-9Mirdametinib CAS 391210-10-9, PD0325901, is a MEK inhibitor and has been approved for the treatment of Neurofibromatosis Type 1 (NF1) in USA.read more
-
RESMETIROM CAS 920509-32-6RESMETIROM CAS 920509-32-6, is a thyroid hormone receptor beta agonist, treatment of Metabolic Dysfunction Associated Steatotic Liver Disease.read more
-
Sparsentan CAS 254740-64-2Sparsentan CAS 254740-64-2, is a dual endothelin A (ETA) and angiotensin II type 1 (AT1) receptor antagonist, treatment of Immunoglobulin A Nephropathy (IgAN).read more
-
Vericiguat CAS 1350653-20-1Vericiguat CAS 1350653-20-1, is a soluble guanylate cyclase (sGC) stimulator, treatment of Heart Failure.read more
-
Viloxazine Hci CAS 35604-67-2Viloxazine Hcl CAS 35604-67-2, is a selective norepinephrine reuptake inhibitor (NRI), also exhibits activity as a 5-HT2C receptor agonist and a 5-HT2B receptor antagonist, treatment of Attention...read more
Mirabegron is used alone or in combination with solifenacin (Vesicare) to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination,...
May 20, 2022 · hives or welts, skin rash. indigestion. itching or pain of the vagina or genital area. pain or tenderness around the eyes and cheekbones. pressure in the stomach. redness of the...
Mirabegron is an orally bioavailable agonist of the human beta-3 adrenergic receptor (ADRB3), with muscle relaxing, neuroprotective and potential antineoplastic activities. Upon oral administration,...
Mirabegron controla los síntomas de la vejiga hiperactiva o la hiperactividad del detrusor neurogénico, pero no cura estas afecciones. Puede tomar 8 semanas o más antes de que...
Myrbetriq (mirabegron) may cause unusual swelling likely due to an allergic reaction (angioedema), which can make it hard to breathe. This can happen right after taking the first dose, or after...
Jul 17, 2021 · Mirabegron is a medication used in the management of overactive bladder. It is in the sympathomimetic class of medications. This activity...
